The role of medical affairs (MA) and disease-state education has become essential in advancing patient care and supporting ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

Patient pathways promise improved treatments and outcomes, yet they often lead to a maze of access, equity and service issues ...

Researchers led by the Institute of Cancer Research (ICR) have identified a potential new treatment approach to slow down the ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

The explosive growth of Gen AI has caused plenty of consternation as well as celebration, but there’s no turning back the ...

The European Medicines Group (EMG) has appointed Sanofi’s Rippon Ubhi as its new chair. Ubhi, who will maintain her position ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

In 2022, there is a renewed focus on diversity, equity and inclusion (DE&I) in the workplace. But for DE&I to be successful, ...

The European Academy of Allergy and Clinical Immunology (EAACI) has launched the first World Anaphylaxis Awareness Day today ...

Merck KGaA and Abbisko Therapeutics have announced positive results from a late-stage study of pimicotinib in patients with ...